Skip to main content

COVID-19 ANALYTICS - 22-4-2020

Image
By

India and the world are grappling with the COVID-19 crisis. Infections and casualties are rising every day, along with recoveries. There are numerous data points that can help us make better sense of this crisis, across India and the world. This COVID-19 Analytics Center brings together relevant data and gives you, the user, control in interpreting them through our intuitive and interactive visualization tools.
INDIA DATA LAST UPDATED: 05:00 PM APRIL 22, 2020

TOTAL CASES

20,471

[+1,486*]

ACTIVE CASES

15,859

[+737*]

DISCHARGED

3,960

[+700*]

DEATHS

652

[+49*]
STATE/UT

TOTAL
20,471
ACTIVE
15,859
DISCHARGED
3,960
DEATHS
652
MAHARASHTRA56494591789269
GUJARAT24072125179103
DELHI2248147672448
RAJASTHAN186817439727
TAMIL NADU162994666218
MADHYA PRADESH1574129319883
UTTAR PRADESH1449125517321
TELENGANA94372519424
ANDHRA PRADESH81366912024
KERALA4371273082
KARNATAKA42727913117
WEST BENGAL3943007915
JAMMU AND KASHMIR407310925
HARYANA2501031443
PUNJAB2571885316
BIHAR14197422
ODISHA8350321
UTTARAKHAND4623230
JHARKHAND463592
HIMACHAL PRADESH3923111
CHHATTISGARH368280
ASSAM3414191
CHANDIGARH2713140
LADAKH182160
ANDAMAN AND NICOBAR0000
MEGHALAYA121101
PUDUCHERRY8341
GOA7070
MANIPUR2020
TRIPURA2110
ARUNACHAL PRADESH1010
MIZORAM1100
LAKSHADWEEP0000
DADRA & NAGAR HAVELI AND DAMAN & DIU0000
SIKKIM0000
NAGALAND1100

Comments

Post a Comment

Popular posts from this blog

Lab-Grown Blood Stem Cells Produced at Last

By
After 20 years of trying, scientists have transformed mature cells into primordial blood cells that regenerate themselves and the components of blood. The work, described today in Nature, offers hope to people with leukaemia and other blood disorders who need bone-marrow transplants but can’t find a compatible donor. If the findings translate into the clinic, these patients could receive lab-grown versions of their own healthy cells. One team, led by stem-cell biologist George Daley of Boston Children’s Hospital in Massachusetts, created human cells that act like blood stem cells, although they are not identical to those found in nature. A second team, led by stem-cell biologist Shahin Rafii of Weill Cornell Medical College in New York City, turned mature cells from mice into fully fledged blood stem cells. “For many years, people have figured out parts of this recipe, but they’ve never quite gotten there,” says Mick Bhatia, a stem-cell researcher at McMaster University i...
Post a Comment
Read more

Mesentery: New organ discovered inside human body by scientists

By
A new organ has been discovered hiding in plain sight inside the  human body . Known as the mesentery, it was previously thought to be just a few fragmented structures in the digestive system. But scientists have realised it is in fact one, continuous organ.  Although its function is still unclear, the discovery opens up “a whole new area of science,” according to J Calvin Coffey, a researcher at the  University Hospital Limerick  who first discovered it.  "When we approach it like every other organ… we can categorise abdominal disease in terms of this organ," he said.   “Now we have established anatomy and the structure. The next step is the function. If you understand the function you can identify abnormal function, and then you have disease.  “Put them all together and you have the field of mesenteric science.” The research has been published in  The Lancet   medical journa...
Post a Comment
Read more

US Moves to Shut Down 2 Big Stem Cell Therapy Clinics

By
Federal authorities Wednesday moved to shut down two of the country’s most prominent for-profit providers of stem cell therapy, one of them a network of clinics with more than 100 offices in the United States, including several in the Bay Area. The Food and Drug Administration filed two complaints in federal court requesting permanent injunctions that would stop Florida-based U.S. Stem Cell Clinic and the California Stem Cell Treatment Center from marketing therapies. Both companies have previously been called out by the FDA for providing unproven, unapproved therapies that could put patients at risk. The injunction requests are an aggressive move by the FDA to patrol the consumer stem cell market. The agency has come under mounting pressure by scientists and patient advocates to increase oversight of the growing consumer market, which has been allowed to flourish for years. “In the two cases filed today, the clinics and their leadership have continued to disregard th...
Post a Comment
Read more